A proposal to declare neurocysticercosis an international reportable disease

Bulletin of the World Health Organization

Volumn 78, Issue 3, 2000, Pages 399-406

  Roman G ^a   Sotelo, J ^b   Del Brutto, O ^c   Flisser, A ^d   Dumas, M ^e   Wadia, N ^f   Botero, D ^g   Cruz, M ^h   Garcia, H ⁱ   De Bittencourt, P R M ^j   Trelles, L ⁱ   Arriagada, C ^k   Lorenzana, P ^l   Nash, T E ^m   Spina Franca A ⁿ  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^c HOSPITAL LUIS VERNAZA   (Ecuador)

^d Instituto Nacional de Diagnostico y Referencia Epidemiologicos   (Mexico)

^e UNIVERSITY OF LIMOGES   (France)

^f JASLOK HOSPITAL AND RESEARCH CENTRE   (India)

^g Instituto Colombiano de Medicina Tropical   (Colombia)

^h Univ Ctrl y Acad Ecuatoriana N   (Ecuador)

ⁱ INSTITUTO NACIONAL DE CIENCIAS NEUROLÓGICAS   (Peru)

^j HOSPITAL NOSSA SENHORA DAS GRAÇAS   (Brazil)

^k UNIVERSITY OF CHILE   (Chile)

^l UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^m NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

ⁿ UNIVERSITY OF SÃO PAULO   (Brazil)

more..

Author keywords

Epidemiological surveillance; International cooperation; Neurocysticercosis, epidemiology

Indexed keywords

DISEASE CONTROL; INFECTIOUS DISEASE; INTERNATIONAL COOPERATION; PARASITE CONTROL;

CONTACT EXAMINATION; FOOD CONTROL; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH SURVEY; HUMAN; INFECTION CONTROL; INTERNATIONAL COOPERATION; NEUROCYSTICERCOSIS; REVIEW;

ADOLESCENT; ADULT; CHILD; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DISEASE NOTIFICATION; HUMANS; INCIDENCE; INTERNATIONAL COOPERATION; MIDDLE AGED; NEUROCYSTICERCOSIS; POPULATION SURVEILLANCE;

EID: 18744419706     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Del Brutto O, Sotelo J, Román GC. Neurocysticercosis: a clinical handbook. Lisse, Netherlands, Swetz & Zeitlinger Publishers, 1998.
2. Flisser A, Madrazo I, Delgado H. [Human cysticercosis]. Mexico DF, Universidad National Autónoma de México and Editera Manual Moderno, 1997 (in Spanish).
3. García HH, Martínez SM, eds. T. solium taeniosis/cysticercosis. Lima, Editotial Universo, 1999.
4. Arriagada C, Nogales-Gaete J, Apt W, eds. [Neurocysticercosis: epidemiological, pathological, immunological, clinical, and therapeutic aspects]. Santiago de Chile, Arrynog Ediciones, 1997 (in Spanish).
5. Botero D, Restrepo M. [Human parasitology]. Third edition. Medellín, Colombia, Editora Corporación para Investigaciones Biológicas, 1998 (in Spanish).
6. Vejjajiva A. Parasitic diseases of the nervous system in Thailand. Clinical and Experimental Neurology, 1978, 15: 92-97.
7. Wadia N, Desai S, Bhatt M. Disseminated cysticercosis: new observations, including CT scan findings and experience with treatment by praziquantel. Brain, 1988, 111: 597-614.
8. Preux PM et al. Cysticercosis and neurocysticercosis in Africa: current status. Neurological Infections and Epidemiology, 1996, 1: 63-68.
9. Avode DG et al. Epilepsy, cysticercosis and neurocysticercosis in Benin. European Neurology, 1998, 39: 60-61.
10. Newell E et al. Prevalence of cysticercosis in epileptics and members of their families in Burundi. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1997, 91: 389-391.
11. Dumas M et al. Epidemiological study of neurocysticercosis in Northern Togo (West Africa). Acta Leidensia, 1989, 57: 191-196.
12. van As AD, Joubert J. Neurocysticercosis in 578 black epileptic patients. South African Medical Journal, 1991, 80: 327-328.
13. International League Against Epilepsy. Commission on Tropical Diseases of the International League against Epilepsy: relationship between epilepsy and tropical diseases. Epilepsia, 1994, 35: 89-93.
14. de Bittencourt PRM et al. Epilepsy in the tropics: I. Epidemiology, socioeconomic risk factors, and etiology. Epilepsia, 1996, 37: 1121-1127.
15. Senanayake N, Roman GC. Epidemiology of epilepsy in developing countries. Bulletin of the World Health Organization, 1993, 71: 247-258.
16. Monteiro L et al. Spectrum of epilepsy in neurocysticercosis: a long-term follow up of 143 patients. Acta Neurologica Scandinavica, 1995, 92: 33-40.
17. Sanchetee PC et al. Epilepsy as a manifestation of neurocysticercosis. Journal of the Association of Physicians of India, 1991, 39: 325-328.
18. Vázquez V, Sotelo J. The course of seizures after treatment of cerebral cysticercosis. New England Journal of Medicine, 1992, 327: 696-701.
19. Del Brutto OH. CT findings in neurologically normal adults with a single generalized seizure. Journal of Epilepsy, 1994, 7: 38-39.
20. Medina MT et al. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Archives of Internal Medicine, 1990, 150: 325-327.
21. García HH et al. Cysticercosis as a major cause of epilepsy in Peru. Lancet, 1993, 341: 197-200.
22. Arruda WO. [Etiology of epilepsy: a prospective study of 210 cases]. Arquivos de Neuro-Psiquiatria, 1991, 49: 251-254 (in Spanish).
23. Chopra JS, Kaur U, Mahajan RC. Cysticercosis and epilepsy: a clinical and serologic study. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1981, 75: 518-520.
24. Dansey RD, Hay M, Cowie RL. Seizures and neurocysticercosis in black men. South African Medical Journal, 1992, 81: 424-425.
25. Alcalá H et al. Neurocysticercosis in Mexican children: report of 29 cases. Annals of Neurology, 1988, 24: 341.
26. Grill L et al. High prevalence of serological markers of cysticercosis among epileptic Malagasy children. Annals of Tropical Paediatrics, 1996, 16: 185-191.
27. San Esteban JE, Flisser A, González-Astiazarán A, eds. [Neurocysticercosis in childhood]. Mexico, Universidad Nacional Autónoma de México and Grupo Editorial Miguel Angel Porrúa, 1997 (in Spanish).
28. Sotelo J, Del Brutto OH, Román GC. Cysticercosis. Current Topics in Infectious Diseases, 1996, 16: 240-259.
29. Cárdenas F et al. Taenia solium ocular cysticercosis: findings in 30 cases. Annals of Ophthalmology, 1992, 24: 25-28.
30. Spina-França A, Livramento JA, Machado LR. Cysticercosis of the central nervous system and cerebrospinal fluid. Immunodiagnosis of 1573 patients in 63 years (1929-1992). Arquivos de Neuro-Psiquiatria, 1993, 51: 16-20.
31. Sotelo J, Guerrero V, Rubio F. Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases. Archives of Internal Medicine, 1985, 145: 442-445.
32. Gemmell M et al. Guidelines for surveillance, prevention and control of taeniasis/cysticercosis. Geneva, World Health Organization, 1983 (unpublished document WHO/VPH/83.49).
33. Flisser A et al, eds. Cysticercosis: present state of knowledge and perspectives. New York, Academic Press, 1982.
34. Yoshino K. Studies on the post-embryonal development of Taenia solium: I. On the hatching of the eggs of Taenia solium. Journal of the Medical Association of Formosa, 1933, 32: 139-141.
35. Gemmel M, Lawson JR. Ovine cysticercosis: an epidemiologic model for the cysticercoses. I. The free-living egg phase. In: Flisser A et al eds. Cysticercosis: present state of knowledge and perspectives. New York, Academic Press, 1982: 87-98.
36. García HH et al. Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. Neurology, 1999, 53: 1582-1584.
37. Centers for Disease Control and Prevention. Recommendations for the International Task Force for Disease Eradication. Morbidity and Mortality Weekly Report, 1993, 42: 1-38.
38. Pawlowski Z. Control of Taenia solium taeniasis and cysticercosis by focus-oriented chemotherapy of taeniasis. Southeast Asian Journal of Tropical Medicine and Public Health, 1991, 22 (Suppl.): 284-286.
39. Schantz PM et al. Potential eradicability of taeniasis and cysticercosis. Bulletin of the Pan American Health Organization, 1993, 27: 397-403.
40. Román GC. Neurology in public health. In: Detels R et al, eds. Oxford Textbook of Public Health, 3rd ed. Oxford, Oxford University Press, 1997: 1195-1223.
41. González AE et al. Effective, single-dose treatment of porcine cysticercosis with oxfendazole. American Journal of Tropical Medicine and Hygiene, 1996, 54: 391-394.
42. Torres A et al. Praziquantel treatment of porcine brain and muscle Taenia solium cysticercosis. 3. Effect of 1-day treatment. Parasitology Research, 1991, 78: 161-164.
43. Lightowlers MW, Rickard MD. Vaccination against cestode parasites. Immunology and Cell Biology, 1993, 71: 443-451.
44. Pathak KM, Gaur SN. Immunization of pigs with culture antigens of Taenia solium. Veterinary Parasitology, 1990, 34: 353-356.
45. Molinari JL et al. Immunization against porcine cysticercosis in an endemic area in Mexico: a field and laboratory study. American Journal of Tropical Medicine and Hygiene, 1993, 49: 502-512.
46. Sciutto E et al. Immunization of pigs against Taenia solium cysticercosis: factors related to effective protection. Veterinary Parasitology, 1995, 60: 53-67.
47. Nascimento E et al. Effective immune protection of pigs against cysticercosis. Veterinary Immunology and Immunopathology, 1995, 45: 127-137.
48. Dietrichs E et al. Cerebral cysticercosis in Norway. Acta Neurologica Scandinavica, 1993, 88: 296-298.
49. Ehnert KL et al. Cysticercosis: first 12 months of reporting in California. Bulletin of the Pan American Health Organization, 1992, 26: 165-169.
50. Centers for Diseases Control and Prevention. Locally acquired neurocysticercosis: North Carolina, Massachusetts and South Carolina, 1989-1991. Morbidity and Mortality Weekly Report, 1992, 41: 1-4.
51. Schantz PM et al. Neurocysticercosis in an Orthodox Jewisin community in New York City. New England Journal of Medicine, 1992, 327: 592-695.
52. Walker J et al. Five cases of neurocysticercosis diagnosed in Sydney. Southeast Asian Journal of Tropical Medicine and Public Health, 199, 22 (Suppl.): 242-244.
53. [Epidemiology and control of taeniasis/cysticercosis in Latin America]. Washington DC, Pan American Health Organization, 1994 (in Spanish).
54. Richards FO et al. Cysticercosis in Los Angeles County. Journal of the American Medical Association, 1985, 254: 3444-3448.
55. Sorvillo FJ et al. Cysticercosis surveillance: locally acquired and travel-related infections and detection of intestinal tapeworm carriers in Los Angeles County. American Journal of Tropical Medicine and Hygiene, 1992, 47: 365-371.
56. García-Pedroza F. [The epidemiology of neurocysticercosis in children in Mexico]. In: San Esteban JE, Flisser A, González Astiazarán A, eds. [Neurocysticercosis in childhood]. Mexico, Universidad Nacional Autónoma de México and Grupo Editorial Miguel Angel Porrúa, 1997: 19-38 (in Spanish).
57. Sarti E et al. Development and evaluation of a health education intervention against Taenia solium in a rural community in Mexico. American Journal of Tropical Medicine and Hygiene, 1997, 56: 127-132.
58. Takayanagui OM. [Neurocysticercosis: prophylaxis]. In: dos Ramos Machado L et al, eds. [Neuroinfection 96]. São Paulo, Clínica Neurológica HC/FMUSP, 1996: 235-243 (in Portuguese).